Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study.
Giaccone G, Kim C, Thompson J, McGuire C, Kallakury B, Chahine JJ, Manning M, Mogg R, Blumenschein WM, Tan MT, Subramaniam DS, Liu SV, Kaplan IM, McCutcheon JN.
Lancet Oncol. 2018 Mar;19(3):347-355. doi: 10.1016/S1470-2045(18)30062-7. Epub 2018 Jan 26.
Thymic Carcinoma With Multiple Paraneoplastic Disorders.
Alexakou Z, Liatsos G, Vasileiou N, Vamvakaris I, Mani I, Alexopoulou A.
Am J Med Sci. 2021 Sep;362(3):324-330. doi: 10.1016/j.amjms.2021.04.012. Epub 2021 May 4.
Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial.
Sato J, Satouchi M, Itoh S, Okuma Y, Niho S, Mizugaki H, Murakami H, Fujisaka Y, Kozuki T, Nakamura K, Nagasaka Y, Kawasaki M, Yamada T, Machida R, Kuchiba A, Ohe Y, Yamamoto N.
Lancet Oncol. 2020 Jun;21(6):843-850. doi: 10.1016/S1470-2045(20)30162-5.
Thymoma and thymic carcinomas.
Scorsetti M, Leo F, Trama A, D'Angelillo R, Serpico D, Macerelli M, Zucali P, Gatta G, Garassino MC.
Crit Rev Oncol Hematol. 2016 Mar;99:332-50. doi: 10.1016/j.critrevonc.2016.01.012. Epub 2016 Jan 19.
Therapeutic options in thymomas and thymic carcinomas.
Muto Y, Okuma Y.
Expert Rev Anticancer Ther. 2022 Apr;22(4):401-413. doi: 10.1080/14737140.2022.2052278. Epub 2022 Apr 4.
Intrathyroidal thymic carcinoma.
Lee Chun Yun C, Lim MY, Bundele MM, Huang Minyi L.
BMJ Case Rep. 2024 Jun 11;17(6):e260938. doi: 10.1136/bcr-2024-260938.
The role of targeted therapy in thymic carcinoma.
Krishnan M, Ganti AK.
J Oncol Pharm Pract. 2019 Oct;25(7):1712-1718. doi: 10.1177/1078155219852758. Epub 2019 Jun 4.
Thymic carcinoma in children.
Yaris N, Nas Y, Cobanoglu U, Yavuz MN.
Pediatr Blood Cancer. 2006 Aug;47(2):224-7. doi: 10.1002/pbc.20468.
Surgical, Radiation, and Systemic Treatments of Patients With Thymic Epithelial Tumors: A Systematic Review.
Falkson CB, Vella ET, Ellis PM, Maziak DE, Ung YC, Yu E.
J Thorac Oncol. 2023 Mar;18(3):299-312. doi: 10.1016/j.jtho.2022.10.016. Epub 2022 Nov 4.
Thymic carcinoma: current and future therapeutic interventions.
Weiss GJ.
Expert Opin Investig Drugs. 2010 Aug;19(8):1007-16. doi: 10.1517/13543784.2010.504708.
